91精品国产手机在线-白筒袜嫩萝双腿之间乳白液体-青青操手机在线视频观看-日本中文字幕人妻日韩-日韩精品在线观看视频网站-天堂资源中文最新版在线一区-欧美专区一区二区三区-国产综合亚洲欧美在线-国产精品久久久久久福利69堂

精雕細(xì)琢,直擊軟肋!抗體微雕的藝術(shù)讓抗HER2治療更上一層樓|奇點(diǎn)深度( 四 )



15.Brezski, R. J. & Georgiou, G. Immunoglobulin isotype knowledge and appli- cation to Fc engineering. Curr. Opin. Immunol. 40, 62–69 (2016).

16.Stavenhagen J B, Gorlatov S, Tuaillon N, et al. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcγ receptors[J]. Cancer research, 2007, 67(18): 8882-8890.

17.Nordstrom J L, Gorlatov S, Zhang W, et al. Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties[J]. Breast Cancer Research, 2011, 13(6): 1-14.

18.Rugo H S, Im S A, Cardoso F, et al. Efficacy of margetuximab vs trastuzumab in patients with pretreated ERBB2-positive advanced breast cancer: a phase 3 randomized clinical trial[J]. JAMA oncology, 2021, 7(4): 573-584.





本文作者丨奇點(diǎn)糕

推薦閱讀